摘要
为应对系统性轻链(AL)型淀粉样变性诊治过程中的诸多挑战,中国AL型淀粉样变性协作组携多学科专家于2016年制定了《系统性轻链型淀粉样变性诊断和治疗指南》,为及时介绍该领域的进展,更好地指导临床实践,协作组近期对指南进行了更新。对AL型淀粉样变性认识的深入,不仅提高了该病的诊断和治疗水平,同时也推动了多学科交叉融合,加快了临床试验的开展和疾病诊疗模式的改进。
To meet the challenges in the diagnosis and treatment of systemic light chain(AL)amyloidosis,the China Systemic Light Chain Amyloidosis Collaborative Group,together with multidisciplinary experts,developed the"Guideline for the Diagnosis and Treatment of Systemic Light Chain Amyloidosis"in 2016.In order to introduce progress in this field and better guide the clinical practice,the guideline has been updated recently.The in-depth understanding of AL amyloidosis has not only improved the level of diagnosis and treatment of the disease,but also promoted the integration of multiple disciplines,accelerated the development of clinical trials and the improvement of disease diagnosis and treatment modes.
作者
黄湘华
刘志红
Huang Xianghua;Liu Zhihong(National Clinical Research Center of Kidney Diseases,Jinling Hospital,Nanjing 210016,China)
出处
《中华医学杂志》
CAS
CSCD
北大核心
2021年第22期1631-1634,共4页
National Medical Journal of China